1987
DOI: 10.1016/s0022-5347(17)43930-9
|View full text |Cite
|
Sign up to set email alerts
|

Complications of Parenteral Nutrition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

1992
1992
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…These are post-surgical patients, critically ill patients with bowel pathology, patients with a poor nutritional status and patients who receive intensive chemotherapy. In 1985 Wolffe [8] examined infectious complications of the use of parenteral nutrition. Organisms isolated were Staphylococci, fungi and Gramnegative bacilli.…”
Section: Introductionmentioning
confidence: 99%
“…These are post-surgical patients, critically ill patients with bowel pathology, patients with a poor nutritional status and patients who receive intensive chemotherapy. In 1985 Wolffe [8] examined infectious complications of the use of parenteral nutrition. Organisms isolated were Staphylococci, fungi and Gramnegative bacilli.…”
Section: Introductionmentioning
confidence: 99%
“…They may be suspected because of difficulty with infusion or withdrawal of blood from a central venous catheter, or because of superior vena cava syndrome, a pulmonary embolism, tricuspid insufficiency, right-sided heart failure, sudden onset of a cardiac murmur, or syncopal episodes. [11][12][13][14] The only clinical sign of a thrombotic infection is often fever or sepsis of unknown origin. 15 As in right-sided endocarditis related to the presence of a central venous catheter, the most frequently encountered pathogens in central venous or right atrial septic thrombosis are Staphylococcus and Candida species.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, if we consider an earlier paper from the same centre [I], with a successful block rate of approximately 66% in the control group and we expect a 20% improvement on this within the study group (unlikely), the appropriate sample size required to show this difference can be calculated by estimating the standardised difference, which is then plotted on a nomogram against the required power of the study [2]. Using a minimal power of 80% and a 20% difference between the control and study groups gives a total study size of 200 patients.…”
Section: The Effect Of Hyaluronidase On Peribulbar Blockmentioning
confidence: 99%